At the end of Ishiro Honda’s Godzilla (1954), a forlorn scientist named Dr. Serizawa ventures to the bottom of Tokyo Bay and ...

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

EQS-News: ParTec AG / Key word (s): Alliance ParTec AG is a Key Technology Provider in EU-Funded SEANERGYS Project for Energy Aware Exascale Computing, Advancing Energy-Efficient HPC in Europe ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...

LONDON/FRANKFURT (Reuters) -Tariffs and Middle East turmoil are spooking European companies and the investors weighing their ...

Acquiring TSB will boost Santander's ranking in UK mortgages to fourth from fifth, RBC estimates. For that, Santander is ...

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

Throughout her career, Danielle Garno has advised global and emerging brands on trademark litigation, influencer deals, ...

Solidcore’s lore is quite colorful for a national fitness chain. It’s the subject of viral TikToks and opinion pieces ...

"Over the past 16 years, Tsinghua University and Bayer have forged a trusted and synergistic partnership that has ...

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb ...